These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27439071)

  • 1. The World Health Organization Measles Programmatic Risk Assessment Tool-Romania, 2015.
    Kriss JL; Stanescu A; Pistol A; Butu C; Goodson JL
    Risk Anal; 2017 Jun; 37(6):1096-1107. PubMed ID: 27439071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of the World Health Organization Measles Programmatic Risk Assessment Tool Using Experience from the 2009 Measles Outbreak in Namibia.
    Kriss JL; De Wee RJ; Lam E; Kaiser R; Shibeshi ME; Ndevaetela EE; Muroua C; Shapumba N; Masresha BG; Goodson JL
    Risk Anal; 2017 Jun; 37(6):1072-1081. PubMed ID: 26895314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The World Health Organization Measles Programmatic Risk Assessment Tool-Pilot Testing in India, 2014.
    Goel K; Naithani S; Bhatt D; Khera A; Sharapov UM; Kriss JL; Goodson JL; Laserson KF; Goel P; Kumar RM; Chauhan LS
    Risk Anal; 2017 Jun; 37(6):1063-1071. PubMed ID: 27088758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of the World Health Organization Programmatic Assessment Tool for Risk of Measles Virus Transmission-Lessons Learned from a Measles Outbreak in Senegal.
    Harris JB; Badiane O; Lam E; Nicholson J; Oumar Ba I; Diallo A; Fall A; Masresha BG; Goodson JL
    Risk Anal; 2016 Sep; 36(9):1708-17. PubMed ID: 26094651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using the World Health Organization Measles Programmatic Risk Assessment Tool for Monitoring of Supplemental Immunization Activities in the Philippines.
    Ducusin MJU; de Quiroz-Castro M; Roesel S; Garcia LC; Cecilio-Elfa D; Schluter WW; Goodson JL; Lam E
    Risk Anal; 2017 Jun; 37(6):1082-1095. PubMed ID: 25950923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a District-Level Programmatic Assessment Tool for Risk of Measles Virus Transmission.
    Lam E; Schluter WW; Masresha BG; Teleb N; Bravo-Alcántara P; Shefer A; Jankovic D; McFarland J; Elfakki E; Takashima Y; Perry RT; Dabbagh AJ; Banerjee K; Strebel PM; Goodson JL
    Risk Anal; 2017 Jun; 37(6):1052-1062. PubMed ID: 25976980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research priorities for accelerating progress toward measles and rubella elimination identified by a cross-sectional web-based survey.
    Kriss JL; Grant GB; Moss WJ; Durrheim DN; Shefer A; Rota PA; Omer SB; Masresha BG; Mulders MN; Hanson M; Linkins RW; Goodson JL
    Vaccine; 2019 Sep; 37(38):5745-5753. PubMed ID: 30898393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress toward measles elimination in Romania after a mass vaccination campaign and implementation of enhanced measles surveillance.
    Pistol A; Hennessey K; Pitigoi D; Ion-Nedelcu N; Lupulescu E; Walls L; Bellini W; Strebel P
    J Infect Dis; 2003 May; 187 Suppl 1():S217-22. PubMed ID: 12721916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress Toward Measles Elimination - European Region, 2009-2018.
    Zimmerman LA; Muscat M; Singh S; Ben Mamou M; Jankovic D; Datta S; Alexander JP; Goodson JL; O'Connor P
    MMWR Morb Mortal Wkly Rep; 2019 May; 68(17):396-401. PubMed ID: 31048675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM; Badizadegan ND
    Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress Toward Rubella Elimination - World Health Organization European Region, 2005-2019.
    O'Connor P; Jankovic D; Zimmerman L; Ben Mamou M; Reef S
    MMWR Morb Mortal Wkly Rep; 2021 Jun; 70(23):833-839. PubMed ID: 34111057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress Toward Measles and Rubella Elimination - India, 2005-2021.
    Murugan R; VanderEnde K; Dhawan V; Haldar P; Chatterjee S; Sharma D; Dzeyie KA; Pattabhiramaiah SB; Khanal S; Sangal L; Bahl S; Tanwar SSS; Morales M; Kassem AM
    MMWR Morb Mortal Wkly Rep; 2022 Dec; 71(50):1569-1575. PubMed ID: 36520657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards elimination of measles and rubella in Italy: Progress and challenges.
    Adamo G; Baccolini V; Massimi A; Barbato D; Cocchiara R; Di Paolo C; Mele A; Cianfanelli S; Angelozzi A; Castellani F; Salerno C; Isonne C; Bella A; Filia A; Del Manso M; Baggieri M; Nicoletti L; Magurano F; Iannazzo S; Marzuillo C; Villari P
    PLoS One; 2019; 14(12):e0226513. PubMed ID: 31841530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research priorities for global measles and rubella control and eradication.
    Goodson JL; Chu SY; Rota PA; Moss WJ; Featherstone DA; Vijayaraghavan M; Thompson KM; Martin R; Reef S; Strebel PM
    Vaccine; 2012 Jul; 30(32):4709-16. PubMed ID: 22549089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress Toward Regional Measles Elimination - Worldwide, 2000-2016.
    Dabbagh A; Patel MK; Dumolard L; Gacic-Dobo M; Mulders MN; Okwo-Bele JM; Kretsinger K; Papania MJ; Rota PA; Goodson JL
    MMWR Morb Mortal Wkly Rep; 2017 Oct; 66(42):1148-1153. PubMed ID: 29073125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress toward measles elimination--European Region, 2005--2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Feb; 58(6):142-5. PubMed ID: 19229166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress Toward Measles Elimination - South-East Asia Region, 2003-2020.
    Khanal S; Kassem AM; Bahl S; Jayantha L; Sangal L; Sharfuzzaman M; Bose AS; Antoni S; Datta D; Alexander JP
    MMWR Morb Mortal Wkly Rep; 2022 Aug; 71(33):1042-1046. PubMed ID: 35980874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global control and regional elimination of measles, 2000-2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Jan; 62(2):27-31. PubMed ID: 23325353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measles and Rubella Global Strategic Plan 2012-2020 midterm review report: Background and summary.
    Orenstein WA; Cairns L; Hinman A; Nkowane B; Olivé JM; Reingold AL
    Vaccine; 2018 Jan; 36 Suppl 1():A35-A42. PubMed ID: 29307368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress Toward Measles Elimination - Nepal, 2007-2014.
    Khanal S; Sedai TR; Choudary GR; Giri JN; Bohara R; Pant R; Gautam M; Sharapov UM; Goodson JL; Alexander J; Dabbagh A; Strebel P; Perry RT; Bah S; Abeysinghe N; Thapa A
    MMWR Morb Mortal Wkly Rep; 2016 Mar; 65(8):206-10. PubMed ID: 26937619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.